The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
Primary Prevention of Coronary Heart Disease: Integrating Risk Assessment With Intervention
Open accessAbstract
T he concept that coronary heart disease (CHD) can be prevented has increasingly become a driving force in cardiovascular medicine.For many years, the field gave lip service to prevention but neglected to take it seriously.The possibility of effective prevention was met with skepticism from many quarters.Gradually, however, the tide has turned, and prevention is getting the upper hand.Widespread acceptance of the benefits of prevention came first in the area of secondary prevention, ie, preventing recurrent coronary events in patients with established CHD. 1 Secondary prevention stands at the boundary between prevention and treatment.Many cardiologists consider secondary prevention to be treatment of coronary artery disease; others see it as prevention of recurrent coronary events.There is a more uniform agreement that prevention of new-onset CHD should be called primary prevention.This article examines some of the major issues currently under scrutiny for primary prevention of CHD.Without question, the area of primary prevention is complex and contentious; some of the issues will not be easily resolved.However, if the burden of CHD in industrialized and developing societies is to be substantially reduced, effective strategies for primary prevention must be put in place. Medical Prevention of Acute Coronary SyndromesMajor advances have recently been made in understanding the pathogenesis of acute coronary syndromes (unstable angina, myocardial infarction, and coronary death).Of great importance was the recognition that rupture of vulnerable plaques leading to coronary thrombosis accounts for most acute coronary syndromes.2,3 Equally important was the discovery that the risk of plaque rupture and its consequences can be substantially reduced by medical intervention.For example, cigarette smoking almost certainly predisposes to plaque rupture, and smoking cessation rapidly lowers risk for coronary thrombosis.4 Meta-analysis confirms that lowering blood pressure in hypertensive patients will reduce acute myocardial infarctions.5 Low-dose aspirin therapy likewise lowers the danger of acute coronary events.6,7 Finally, recent clinical trials 8 -12 demonstrate that cholesterol-lowering therapy will reduce risk for major coronary events beyond previous expectations.Thus, preventive medical therapies are now available to intervene on coronary atherosclerotic disease before it becomes clinically manifest.Appropriate selection of patients for aggressive primary prevention thus emerges as a critical issue.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Self-citationPrediction of coronary heart disease using risk factor categories
Wilson, P. W. F., D’Agostino, R. B., Levy, D., Belanger, A. M., Silbershatz, H., & Kannel, W. B. (1998) · Circulation · doi:10.1161/01.cir.97.18.1837 · Cited by 9,581
(1998) · PsycEXTRA Dataset · doi:10.1037/e565682010-001 · Cited by 9,472
OLSSON, A. G., McMurray, J. J. V., Thorgeirsson, G., Spaulding, C. M., Slattery, J., Pyörälà, K., Færgeman, O., Wright, R. S., Berg, K. M., Wilhelmsen, L., et al. (1994) · The Lancet · Cited by 8,467
Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
Shepherd, J., Cobbe, S. M., Ford, I., Isles, C. G., Lorimer, A. R., Macfarlane, P. W., McKillop, J. H., & Packard, C. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511163332001 · Cited by 7,449
Sacks, F. M., Pfeffer, M. A., Moye, L. A., Rouleau, J. L., Rutherford, J. D., Cole, T. G., Brown, L., Warnica, J. W., Arnold, J. M. O., Wun, C.-C., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610033351401 · Cited by 7,439
Haffner, S. M., Lehto, S., Rönnemaa, T., Pyörälä, K., & Laakso, M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807233390404 · Cited by 7,000
Physical Activity and Health: A Report of the Surgeon General: (525162010-001)
(1995) · PsycEXTRA Dataset · doi:10.1037/e525162010-001 · Cited by 5,479
(1998) · New England Journal of Medicine · doi:10.1056/nejm199811053391902 · Cited by 5,261
Downs, J. R., Clearfield, M., Weis, S., Whitney, E., Shapiro, D. R., Beere, P. A., Langendorfer, A., Stein, E. A., Kruyer, W., Gotto, Jr., et al. (1998) · JAMA · doi:10.1001/jama.279.20.1615 · Cited by 5,236
Cited by
General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study
D’Agostino, R. B., Vasan, R. S., Pencina, M. J., Wolf, P. A., Cobain, M., Massaro, J. M., & Kannel, W. B. (2008) · Circulation · doi:10.1161/circulationaha.107.699579 · Cited by 7,491
Grundy, S. M., Pasternak, R., Greenland, P., Smith, S., & Fuster, V. (1999) · Circulation · doi:10.1161/01.cir.100.13.1481 · Cited by 1,315
Self-citationWaging war on modern chronic diseases: primary prevention through exercise biology
Booth, F. W., Gordon, S. E., Carlson, C. J., & Hamilton, M. T. (2000) · Journal of Applied Physiology · doi:10.1152/jappl.2000.88.2.774 · Cited by 693
Grundy, S. M. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.14.1568 · Cited by 551
Self-citationGreenland, P., Smith Jr, S. C., & Grundy, S. M. (2001) · Circulation · doi:10.1161/hc4201.097189 · Cited by 553
Self-citation
Metadata
- Authors
- Grundy, S. M.
- Venue
- Circulation
- Published
- 1999-08-31
- Volume
- 100
- Issue
- 9
- Pages
- 988-998
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2106443653
- Cited by
- 265
- References
- 98
- FWCI
- 25.77
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Primary Prevention of Coronary Heart Disease: Integrating Risk Assessment With Intervention. https://app.cochat.ai/papers/10.1161/01.cir.100.9.988
- The paper
- Grundy, S. M. (1999). Primary Prevention of Coronary Heart Disease: Integrating Risk Assessment With Intervention. Circulation. https://doi.org/10.1161/01.cir.100.9.988
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.